GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » athenahealth Inc (NAS:ATHN) » Definitions » Intrinsic Value: Projected FCF

athenahealth (athenahealth) Intrinsic Value: Projected FCF : $0.00 (As of Apr. 30, 2024)


View and export this data going back to 2007. Start your Free Trial

What is athenahealth Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-04-30), athenahealth's Intrinsic Value: Projected FCF is $0.00. The stock price of athenahealth is $9.95. Therefore, athenahealth's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for athenahealth's Intrinsic Value: Projected FCF or its related term are showing as below:

ATHN's Price-to-Projected-FCF is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.31
* Ranked among companies with meaningful Price-to-Projected-FCF only.

athenahealth Intrinsic Value: Projected FCF Historical Data

The historical data trend for athenahealth's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

athenahealth Intrinsic Value: Projected FCF Chart

athenahealth Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.60 20.09 18.07 19.61 24.94

athenahealth Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.28 24.94 28.59 33.70 38.54

Competitive Comparison of athenahealth's Intrinsic Value: Projected FCF

For the Health Information Services subindustry, athenahealth's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


athenahealth's Price-to-Projected-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, athenahealth's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where athenahealth's Price-to-Projected-FCF falls into.



athenahealth Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get athenahealth's Free Cash Flow(6 year avg) = $50.02.

athenahealth's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Sep18)*0.8)/Shares Outstanding (Diluted Average)
=(14.862653310476*50.02416+1067.9*0.8)/41.200
=38.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


athenahealth  (NAS:ATHN) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

athenahealth's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=9.95/38.781838524946
=0.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


athenahealth Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of athenahealth's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


athenahealth (athenahealth) Business Description

Traded in Other Exchanges
N/A
Address
Athenahealth provides healthcare IT (HCIT) services through cloud-based and mobile application products largely for smaller to midsize medical groups and health systems. Their services include revenue cycle and practice management, electronic health records, patient engagement, population health management, and care coordination. The business services segment generates 96% of revenue, which provides cloud-based solutions and support to healthcare providers. Athenahealth is headquartered in Waltham, Massachusetts.
Executives
Brian P Mckeon director IDEXX LABORATORIES, ONE IDEXX DRIVE, WESTBROOK ME 04092
John A Kane director C/O MERCHANTS BANCSHARES, INC., 275 KENNEDY DRIVE, SOUTH BURLINGTON VT 05403
Dev Ittycheria director C/O MONGO DB, INC., 1633 BROADWAY, 38TH FLOOR, NEW YORK NY 10019
Ed Park director 311 ARSENAL STREET WATERTOWN MA 02472
Brandon H Hull director 221 NASSAU STREET, PRINCETON NJ 08542
Thomas J Szkutak director P O BOX 81226, SEATTLE WA 98108-1226
Jeffrey R Immelt director, other: Executive Chairman GENERAL ELECTRIC COMPANY, 41 FARNSWORTH STREET, BOSTON MA 02210
Marc A Levine officer: Chief Financial Officer C/O ATHENAHEALTH, INC., 311 ARSENAL STREET, WATERTOWN MA 02472
Jacqueline B Kosecoff director 5960 HEISLEY ROAD, MENTOR OH 44060
Amy Abernethy director 311 ARSENAL STREET, WATERTOWN MA 02472
Kristi Ann Matus officer: EVP and CFAO C/O EQUITABLE HOLDINGS, INC., 1290 AVENUE OF THE AMERICAS, NEW YORK NY 10104
Daniel H. Orenstein officer: SVP, GC, and Secretary 311 ARSENAL STREET, WATERTOWN MA 02472
Jeremy Delinsky officer: SVP, Chief Product Officer C/O WAYFAIR INC., 4 COPLEY PLACE, 7TH FLOOR, BOSTON MA 02116
Timothy M Adams officer: CFO & SVP 311 ARSENAL STREET, WATERTOWN MA 02472
Bryan E Roberts director C/O VENROCK ASSOCIATES, 2494 SAND HILL ROAD STE 200, MENLO PARK CA 94025

athenahealth (athenahealth) Headlines

From GuruFocus